Literature DB >> 21655405

Assessment of the pharmacogenomics educational needs of pharmacists.

Kristen B McCullough1, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson.   

Abstract

OBJECTIVES: To evaluate the self-perceived knowledge and confidence of inpatient and outpatient pharmacists in applying pharmacogenomics information to clinical practice.
METHODS: A 19-question multiple-choice, electronic needs-assessment survey instrument was distributed to 480 inpatient and outpatient pharmacists in a large, academic, multi-campus healthcare system.
RESULTS: The survey response rate was 64% (303). Most respondents (85%) agreed that pharmacists should be required to be knowledgeable about pharmacogenomics, and 65% agreed that pharmacists should be capable of providing information on the appropriate use of pharmacogenomics testing. Sixty-three percent felt they could not accurately apply the results of pharmacogenomics tests to drug-therapy selection, dosing, or monitoring.
CONCLUSION: Pharmacists believe pharmacogenomics knowledge is important to the profession, but they lack the knowledge and self-confidence to act on the results of pharmacogenomics testing and may benefit from pharmacogenomics education.

Entities:  

Keywords:  continuing education; genetic testing; needs assessment; pharmacogenomics; survey

Mesh:

Year:  2011        PMID: 21655405      PMCID: PMC3109805          DOI: 10.5688/ajpe75351

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  19 in total

1.  Physicians' expectations of pharmacists.

Authors:  William E Smith; Max D Ray; David M Shannon
Journal:  Am J Health Syst Pharm       Date:  2002-01-01       Impact factor: 2.637

2.  Pharmacogenomics--drug disposition, drug targets, and side effects.

Authors:  William E Evans; Howard L McLeod
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 3.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

4.  Inventing the pharmacogenomics business.

Authors:  A Regalado
Journal:  Am J Health Syst Pharm       Date:  1999-01-01       Impact factor: 2.637

Review 5.  ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  David R Holmes; Gregory J Dehmer; Sanjay Kaul; Dana Leifer; Patrick T O'Gara; C Michael Stein
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

6.  Pharmacy beyond the dispensary: general practitioners' views.

Authors:  J A Spencer; C Edwards
Journal:  BMJ       Date:  1992-06-27

7.  Nurses' perceived knowledge, beliefs, skills, and needs regarding evidence-based practice: implications for accelerating the paradigm shift.

Authors:  Bernadette Mazurek Melnyk; Ellen Fineout-Overholt; Nancy Fischbeck Feinstein; Hong Li; Leigh Small; Larry Wilcox; Rachel Kraus
Journal:  Worldviews Evid Based Nurs       Date:  2004       Impact factor: 2.931

8.  The research agenda of the American College of Clinical Pharmacy.

Authors: 
Journal:  Pharmacotherapy       Date:  2007-02       Impact factor: 4.705

9.  Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years.

Authors:  Daniel S Streetman
Journal:  Ann Pharmacother       Date:  2007-10-23       Impact factor: 3.154

10.  Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine.

Authors:  David Gurwitz; Abraham Weizman; Moshe Rehavi
Journal:  Trends Pharmacol Sci       Date:  2003-03       Impact factor: 14.819

View more
  70 in total

1.  A pharmacogenetics service experience for pharmacy students, residents, and fellows.

Authors:  Katarzyna Drozda; Yana Labinov; Ruixuan Jiang; Margaret R Thomas; Shan S Wong; Shitalben Patel; Edith A Nutescu; Larisa H Cavallari
Journal:  Am J Pharm Educ       Date:  2013-10-14       Impact factor: 2.047

2.  Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.

Authors:  John Valgus; Kristin W Weitzel; Josh F Peterson; Daniel J Crona; Christine M Formea
Journal:  Am J Health Syst Pharm       Date:  2019-04-08       Impact factor: 2.637

3.  Application of genomic principles to pharmacotherapy of cancer.

Authors:  Christopher L Farrell; Nancy G Pedigo; Amy R Messersmith
Journal:  Am J Pharm Educ       Date:  2014-04-17       Impact factor: 2.047

4.  Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.

Authors:  Sony Tuteja; Kevin Haynes; Cara Zayac; Jon E Sprague; Barbara Bernhardt; Reed Pyeritz
Journal:  Per Med       Date:  2013-11       Impact factor: 2.512

Review 5.  Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors:  Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal:  Patient Educ Couns       Date:  2014-06-21

6.  Pharmacy students' attitudes and perceptions toward pharmacogenomics education.

Authors:  Shanice Coriolan; Nimota Arikawe; Arden Moscati; Lisheng Zhou; Stephanie Dym; Seda Donmez; Adinoyi Garba; Sasha Falbaum; Zvi Loewy; Melinda Lull; Maha Saad; Jane Shtaynberg; Aniwaa Owusu Obeng
Journal:  Am J Health Syst Pharm       Date:  2019-05-17       Impact factor: 2.637

7.  Pharmacogenomics courses in pharmacy school curricula.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenomics       Date:  2019-06       Impact factor: 2.533

8.  Pharmacogenomics Education Improves Pharmacy Student Perceptions of Their Abilities and Roles in Its Use.

Authors:  Rebecca Marcinak; Meaghan Paris; Shannon R M Kinney
Journal:  Am J Pharm Educ       Date:  2018-11       Impact factor: 2.047

Review 9.  The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Authors:  Mafalda M Dias; Michael J Sorich; Andrew Rowland; Michael D Wiese; Ross A McKinnon
Journal:  Pharm Res       Date:  2017-02-24       Impact factor: 4.200

Review 10.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.